» Articles » PMID: 37656618

Irreversible Cell Cycle Exit Associated with Senescence is Mediated by Constitutive MYC Degradation

Overview
Journal Cell Rep
Publisher Cell Press
Date 2023 Sep 1
PMID 37656618
Authors
Affiliations
Soon will be listed here.
Abstract

Cells can irreversibly exit the cell cycle and become senescent to safeguard against uncontrolled proliferation. While the p53-p21 and p16-Rb pathways are thought to mediate senescence, they also mediate reversible cell cycle arrest (quiescence), raising the question of whether senescence is actually reversible or whether alternative mechanisms underly the irreversibility associated with senescence. Here, we show that senescence is irreversible and that commitment to and maintenance of senescence are mediated by irreversible MYC degradation. Senescent cells start dividing when a non-degradable MYC mutant is expressed, and quiescent cells convert to senescence when MYC is knocked down. In early oral carcinogenesis, epithelial cells exhibit MYC loss and become senescent as a safeguard against malignant transformation. Later stages of oral premalignant lesions exhibit elevated MYC levels and cellular dysplasia. Thus, irreversible cell cycle exit associated with senescence is mediated by constitutive MYC degradation, but bypassing this degradation may allow tumor cells to escape during cancer initiation.

Citing Articles

Fantastic Frogs and Where to Use Them: Unveiling the Hidden Cinobufagin's Promise in Combating Lung Cancer Development and Progression Through a Systematic Review of Preclinical Evidence.

Barbalho S, Pomini K, de Lima E, da Silva Camarinha Oliveira J, Leme Boaro B, Cressoni Araujo A Cancers (Basel). 2024; 16(22).

PMID: 39594713 PMC: 11592936. DOI: 10.3390/cancers16223758.


Patient-specific computational models predict prognosis in B cell lymphoma by quantifying pro-proliferative and anti-apoptotic signatures from genetic sequencing data.

Norris R, Jones J, Mancini E, Chevassut T, Simoes F, Pepper C Blood Cancer J. 2024; 14(1):105.

PMID: 38965209 PMC: 11224250. DOI: 10.1038/s41408-024-01090-y.


Therapy-induced senescence is finally escapable, what is next?.

Saleh T Cell Cycle. 2024; 23(6):713-721.

PMID: 38879812 PMC: 11229739. DOI: 10.1080/15384101.2024.2364579.


Modulation of tumor plasticity by senescent cells: Deciphering basic mechanisms and survival pathways to unravel therapeutic options.

Silva A, Bitencourt T, Vargas J, Fraga L, Filippi-Chiela E Genet Mol Biol. 2024; 47Suppl 1(Suppl 1):e20230311.

PMID: 38805699 PMC: 11132560. DOI: 10.1590/1678-4685-GMB-2023-0311.


A Conversation with ChatGPT on Contentious Issues in Senescence and Cancer Research.

Elshazly A, Shahin U, Al Shboul S, Gewirtz D, Saleh T Mol Pharmacol. 2024; 105(5):313-327.

PMID: 38458774 PMC: 11026153. DOI: 10.1124/molpharm.124.000871.


References
1.
Fletcher-Sananikone E, Kanji S, Tomimatsu N, Di Cristofaro L, Kollipara R, Saha D . Elimination of Radiation-Induced Senescence in the Brain Tumor Microenvironment Attenuates Glioblastoma Recurrence. Cancer Res. 2021; 81(23):5935-5947. PMC: 9724593. DOI: 10.1158/0008-5472.CAN-21-0752. View

2.
Jun J, Lau L . Cellular senescence controls fibrosis in wound healing. Aging (Albany NY). 2010; 2(9):627-31. PMC: 2984611. DOI: 10.18632/aging.100201. View

3.
Campisi J, dAdda di Fagagna F . Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007; 8(9):729-40. DOI: 10.1038/nrm2233. View

4.
Tao Y, Wang N, Xu L, Li Z, Li X, Xu Y . Molecular mechanism of G arrest and cellular senescence induced by LEE011, a novel CDK4/CDK6 inhibitor, in leukemia cells. Cancer Cell Int. 2017; 17:35. PMC: 5340031. DOI: 10.1186/s12935-017-0405-y. View

5.
Pandey K, Park N, Park K, Hur J, Cho Y, Kang M . Combined CDK2 and CDK4/6 Inhibition Overcomes Palbociclib Resistance in Breast Cancer by Enhancing Senescence. Cancers (Basel). 2020; 12(12). PMC: 7768442. DOI: 10.3390/cancers12123566. View